CoChat

Substance use disorders and psychiatric comorbidity in mid and later life: a review

Open access
Wu, L.-T., Blazer, D. G. · 2014 · International Journal of Epidemiology

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Globally, adults aged 65 years or older will increase from 516 million in 2009 to an estimated 1.53 billion in 2050. Due to substance use at earlier ages that may continue into later life, and ageing-related changes in medical conditions, older substance users are at risk for substance-related consequences. METHODS: MEDLINE and PsychInfo databases were searched using keywords: alcohol use disorder, drug use disorder, drug misuse, substance use disorder, prescription drug abuse, and substance abuse. Using the related-articles link, additional articles were screened for inclusion. This review focused on original studies published between 2005 and 2013 to reflect recent trends in substance use disorders. Studies on psychiatric comorbidity were also reviewed to inform treatment needs for older adults with a substance use disorder. RESULTS: Among community non-institutionalized adults aged 50+ years, about 60% used alcohol, 3% used illicit drugs and 1-2% used nonmedical prescription drugs in the past year. Among adults aged 50+, about 5% of men and 1.4% of women had a past-year alcohol use disorder. Among alcohol users, about one in 14 users aged 50-64 had a past-year alcohol use disorder vs one in 30 elder users aged 65+. Among drug users aged 50+, approximately 10-12% had a drug use disorder. Similar to depressive and anxiety disorders, substance use disorders were among the common psychiatric disorders among older adults. Older drug users in methadone maintenance treatment exhibited multiple psychiatric or medical conditions. There have been increases in treatment admissions for illicit and prescription drug problems in the United States. CONCLUSIONS: Substance use in late life requires surveillance and research, including tracking substance use in the racial/ethnic populations and developing effective care models to address comorbid medical and mental health problems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyt173

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 6

  1. 2011, 2, 77
  2. 2013, 4, 3
  3. Arndt, 2005, American Journal of Geriatric Psychiatry, 13, 385, 10.1097/00019442-200505000-00007 · doi:10.1097/00019442-200505000-00007
  4. Pilowsky, 2012, 3, 25
  5. 2012, 3, 1
  6. 2012, MMWR. Morbidity and mortality weekly report, 61, 10

Cited by

See all 165

Metadata

Authors
Wu, L.-T., & Blazer, D. G.
Affiliations
Duke Medical Center (US)
Corresponding author
Blazer, D. G.
Venue
International Journal of Epidemiology
Published
2013-10-24
Volume
43
Issue
2
Pages
304-317
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2105035516
Cited by
149
References
48
Citations by year
2026: 7 · 2025: 11 · 2024: 11 · 2023: 10 · 2022: 15 · 2021: 7 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 10 · 2016: 14 · 2015: 10 · 2014: 7
FWCI
1.22
Type
journal article
Language
en
Open access
Locations
  • International Journal of Epidemiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service (HSN271200522071C)
  • National Institute on Drug Abuse (R21DA027503, R01DA019623, R33DA027503, R01DA019901)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
substance use disorders, older adults, psychiatric comorbidity, alcoholism, drug use disorders, prescription drug misuse, illicit drug use, methadone maintenance treatment, depressive disorders, anxiety disorders, aging, substance use surveillance, treatment admissions
MeSH terms
Aged, Mental Disorders, Female, Humans, Male, Middle Aged, Global Health, Incidence, Diagnosis, Dual (Psychiatry), Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Substance use disorders and psychiatric comorbidity in mid and later life: a review. https://app.cochat.ai/papers/10.1093/ije/dyt173
The paper
Wu, L.-T., & Blazer, D. G. (2014). Substance use disorders and psychiatric comorbidity in mid and later life: a review. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyt173

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.